Literature DB >> 2860352

Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin.

G Berlin, A Selbing, G Ryden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860352     DOI: 10.1016/s0140-6736(85)92451-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Immunoglobulin therapy in immunohematological disorders.

Authors:  V P Choudhry; M Mahapatra; R Kashyap
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

2.  Immune phagocytosis inhibition by commercial immunoglobulins.

Authors:  J Neppert; M Clemens; C Mueller-Eckhardt
Journal:  Blut       Date:  1986-02

3.  Can high-dose immunoglobulin therapy be indicated in neonatal rhesus haemolysis? A successful case of haemolytic disease due to rhesus (c + E) incompatibility.

Authors:  S Kubo; T Ariga; H Tsuneta; T Ishii
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

4.  Antenatal treatment of fetal alloimmune cytopenias.

Authors:  J B Bussel; J G McFarland; R Berkowitz
Journal:  Blut       Date:  1989-07

5.  Efficacy of Antenatal Intravenous Immunoglobulin Treatment in Pregnancies at High Risk due to Alloimmunization to Red Blood Cells.

Authors:  Beate Mayer; Larry Hinkson; Wiebke Hillebrand; Wolfgang Henrich; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2018-10-31       Impact factor: 3.747

6.  Successful treatment of fetal intraperitoneal administration of immunoglobulin in a case of fetal hemolytic anemia with 131,072-fold anti-e alloimmunization.

Authors:  Masashi Yoshida; Hideo Matsuda; Eijiro Hayata; Akio Watanabe; Miho Oeda; Kenichi Furuya
Journal:  Case Rep Obstet Gynecol       Date:  2011-11-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.